Purpose HIV-infected individuals with cancer have worse survival rates compared with their
HIV-uninfected counterparts. One explanation may be differing cancer treatment; however, …

BRAF kinase gene V600 point mutations drive approximately 40% to 50% of all melanomas,
and BRAF inhibitors (BRAFi) have been found to significantly improve survival outcomes. …

Purpose Despite advances in the treatment of HIV, HIV-infected people remain at increased
risk for many cancers, and the number of non–AIDS-defining cancers is increasing with the …

Background People living with HIV (PLWH) are at an increased risk of developing several
cancers, but to the authors’ knowledge less is known regarding how HIV impacts the rate of …

It is suspected that primary central nervous system lymphoma ( PCNSL ) rates are increasing
among immunocompetent people. We estimated PCNSL trends in incidence and survival …

Objectives: HIV-infected people have elevated risk for lung cancer and higher mortality
following cancer diagnosis than HIV-uninfected individuals. It is unclear whether HIV-infected …

Purpose Cervical cancer is the leading cause of cancer death among the 20 million women
with HIV worldwide. We sought to determine whether HIV infection affected survival in …

Background Transgender persons face many barriers to health care that may delay cancer
diagnosis and treatment, possibly resulting in decreased survival. Yet, data on cancer in this …

BACKGROUND Patients with cancer who are infected with the human immunodeficiency virus
(HIV) are less likely to receive cancer treatment compared with HIV‐uninfected individuals…

Purpose: HIV-infected individuals with non–AIDS-defining cancers are less likely to receive
cancer treatment compared with uninfected individuals. We sought to identify provider-level …